Search research articles
Contact Us
Filters
Showing results (191-200 of 216) with videos related to
Page
of 22
Sort By:
CPT: Pharmacometrics & Systems Pharmacology
|
September 18, 2016
Population Pharmacokinetics and Pharmacodynamics of the Calcimimetic Etelcalcetide in Chronic Kidney Disease and Secondary Hyperparathyroidism Receiving Hemodialysis
P Chen, P Olsson Gisleskog, J J Perez-Ruixo, et al.
Bioconjugate Chemistry
|
May 29, 1999
Closo-dodecaborate(2-) as a linker for iodination of macromolecules. Aspects on conjugation chemistry and biodistribution
V Tolmachev, J Koziorowski, I Sivaev, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 1, 1996
In vitro determination of toxicity, binding, retention, subcellular distribution and biological efficacy of the boron neutron capture agent DAC-1
N Tilly, P Olsson, T Hartman, et al.
Anesthesiology
|
July 1, 1987
Treatment of acute respiratory failure by extracorporeal carbon dioxide elimination performed with a surface heparinized artificial lung
L Bindslev, J Eklund, O Norlander, et al.
Rhinology
|
March 1, 1995
A comparison of budesonide nasal dry powder with fluticasone propionate aqueous nasal spray in patients with perennial allergic rhinitis
M Andersson, R Berglund, L Greiff, et al.
Gene
|
March 20, 2001
ERGL, a novel gene related to ERGIC-53 that is highly expressed in normal and neoplastic prostate and several other tissues
N Yerushalmi, A Keppler-Hafkemeyer, G Vasmatzis, et al.
International Journal of Radiation Biology
|
February 17, 1998
Uptake, toxicity and radiation effects of the boron compounds DAAC-1 and DAC-1 in cultured human glioma cells
P Olsson, M Black, J Capala, et al.
The New England Journal of Medicine
|
October 14, 2011
Randomized trial of oral teriflunomide for relapsing multiple sclerosis
Paul O'Connor, Jerry S Wolinsky, Christian Confavreux, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 18, 2017
The efficacy of teriflunomide in patients who received prior disease-modifying treatments: Subgroup analyses of the teriflunomide phase 3 TEMSO and TOWER studies
Mark S Freedman, Jerry S Wolinsky, Giancarlo Comi, et al.
Intensive Care Medicine
|
January 1, 1988
Extracorporeal CO2-removal with a heparin coated artificial lung
J Peters, P Radermacher, M E Kuntz, et al.
Page
of 22
Search research articles
Search
Showing results (191-200 of 216) with videos related to
Sort By:
Page
of 22
CPT: Pharmacometrics & Systems Pharmacology
|
September 18, 2016
Population Pharmacokinetics and Pharmacodynamics of the Calcimimetic Etelcalcetide in Chronic Kidney Disease and Secondary Hyperparathyroidism Receiving Hemodialysis
P Chen, P Olsson Gisleskog, J J Perez-Ruixo, et al.
Bioconjugate Chemistry
|
May 29, 1999
Closo-dodecaborate(2-) as a linker for iodination of macromolecules. Aspects on conjugation chemistry and biodistribution
V Tolmachev, J Koziorowski, I Sivaev, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 1, 1996
In vitro determination of toxicity, binding, retention, subcellular distribution and biological efficacy of the boron neutron capture agent DAC-1
N Tilly, P Olsson, T Hartman, et al.
Anesthesiology
|
July 1, 1987
Treatment of acute respiratory failure by extracorporeal carbon dioxide elimination performed with a surface heparinized artificial lung
L Bindslev, J Eklund, O Norlander, et al.
Rhinology
|
March 1, 1995
A comparison of budesonide nasal dry powder with fluticasone propionate aqueous nasal spray in patients with perennial allergic rhinitis
M Andersson, R Berglund, L Greiff, et al.
Gene
|
March 20, 2001
ERGL, a novel gene related to ERGIC-53 that is highly expressed in normal and neoplastic prostate and several other tissues
N Yerushalmi, A Keppler-Hafkemeyer, G Vasmatzis, et al.
International Journal of Radiation Biology
|
February 17, 1998
Uptake, toxicity and radiation effects of the boron compounds DAAC-1 and DAC-1 in cultured human glioma cells
P Olsson, M Black, J Capala, et al.
The New England Journal of Medicine
|
October 14, 2011
Randomized trial of oral teriflunomide for relapsing multiple sclerosis
Paul O'Connor, Jerry S Wolinsky, Christian Confavreux, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 18, 2017
The efficacy of teriflunomide in patients who received prior disease-modifying treatments: Subgroup analyses of the teriflunomide phase 3 TEMSO and TOWER studies
Mark S Freedman, Jerry S Wolinsky, Giancarlo Comi, et al.
Intensive Care Medicine
|
January 1, 1988
Extracorporeal CO2-removal with a heparin coated artificial lung
J Peters, P Radermacher, M E Kuntz, et al.
Page
of 22